Jessica Oien

President at BOUNDLESS BIO, INC.

Net worth: - $ as of 31/07/2026

55 year

68 connections

Health Technology

Consumer Services

Commercial Services

Profile

Jessica Oien is currently President, Secretary & Chief Legal Officer at Boundless Bio, Inc., starting in 2026.
Former positions include Senior Director-Legal Affairs at Verus Pharmaceuticals, Inc. from 2007 to 2008; Senior Director-Legal Affairs at Elan Pharmaceuticals LLC from 2001 to 2007; Vice President-Compliance at Otonomy, Inc. from 2015 to 2018; Senior Vice President & General Counsel at Cidara Therapeutics, Inc. in 2018; Vice President-Legal Affairs & Compliance at Somaxon Pharmaceuticals, Inc.; Counsel at Brobeck, Phleger & Harrison LLP; Vice President-Legal & Compliance at Pernix Therapeutics Holdings, Inc.; Counsel at Milbank Tweed Hadley & Mccloy LLP (Singapore).
Education includes undergraduate studies at North Dakota State University and graduate studies at Loyola Law School.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BOUNDLESS BIO INC. -.--%	23/01/2026	0 ( -.--% )	- $	31/07/2026

Jessica Oien active positions

Companies	Position	Start
BOUNDLESS BIO, INC.	President	01/07/2026

All active positions of Jessica Oien

Former positions of Jessica Oien

Companies	Position	End
CIDARA THERAPEUTICS	General Counsel	01/09/2021
OTONOMY	Compliance Officer	01/01/2018
Verus Pharmaceuticals, Inc. Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pediatric-oriented pharmaceutical products	General Counsel	01/01/2008
Elan Pharmaceuticals LLC Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	General Counsel	01/01/2007
Milbank Tweed Hadley & Mccloy LLP (Singapore) Milbank Tweed Hadley & Mccloy LLP (Singapore) Miscellaneous Commercial ServicesCommercial Services Provides legal services	General Counsel	-

See the detail of Jessica Oien's experience

Training of Jessica Oien

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jessica Oien's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Somaxon Pharmaceuticals, Inc. Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products	Health Technology
Verus Pharmaceuticals, Inc. Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pediatric-oriented pharmaceutical products	Health Technology
Elan Pharmaceuticals LLC Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
North Dakota State University North Dakota State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Brobeck, Phleger & Harrison LLP Brobeck, Phleger & Harrison LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services	Commercial Services
Loyola Law School Loyola Law School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Otonomy, Inc. Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases	Health Technology
Pernix Therapeutics Holdings, Inc. Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products	Health Technology
Cidara Therapeutics, Inc. Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives	Health Technology
Milbank Tweed Hadley & Mccloy LLP (Singapore) Milbank Tweed Hadley & Mccloy LLP (Singapore) Miscellaneous Commercial ServicesCommercial Services Provides legal services	Commercial Services
Boundless Bio, Inc. Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics	Health Technology